Tumour-initiating cells: challenges and opportunities for anticancer drug discovery

被引：702

作者：

Zhou, Bin-Bing S. ^{[1
]}

Zhang, Haiying ^{[2
]}

Damelin, Marc ^{[1
]}

Geles, Kenneth G. ^{[1
]}

Grindley, Justin C. ^{[1
]}

Dirks, Peter B. ^{[3
]}

机构：

[1] Wyeth Res, Oncol Discovery, Pearl River, NY 10965 USA

[2] Abbott Labs, Abbott Pk, IL 60064 USA

[3] Hosp Sick Children, Toronto, ON M4G 1X8, Canada

来源：

NATURE REVIEWS DRUG DISCOVERY | 2009年 / 8卷 / 10期

关键词：

CANCER STEM-CELLS; ACUTE MYELOID-LEUKEMIA; EPITHELIAL-MESENCHYMAL TRANSITION; ACUTE MYELOGENOUS LEUKEMIA; SIDE-POPULATION PHENOTYPE; SMALL-MOLECULE INHIBITOR; HUMAN BREAST-CANCER; ABILITY IN-VITRO; HEMATOPOIETIC STEM; SELF-RENEWAL;

D O I：

10.1038/nrd2137

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

The hypothesis that cancer is driven by tumour-initiating cells (popularly known as cancer stem cells) has recently attracted a great deal of attention, owing to the promise of a novel cellular target for the treatment of haematopoietic and solid malignancies. Furthermore, it seems that tumour-initiating cells might be resistant to many conventional cancer therapies, which might explain the limitations of these agents in curing human malignancies. Although much work is still needed to identify and characterize tumour-initiating cells, efforts are now being directed towards identifying therapeutic strategies that could target these cells. This Review considers recent advances in the cancer stem cell field, focusing on the challenges and opportunities for anticancer drug discovery.

引用

页码：806 / 823

页数：18

共 206 条

[61] Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1 [J].

Gonzalez, M. E. ;

Li, X. ;

Toy, K. ;

DuPrie, M. ;

Ventura, A. C. ;

Banerjee, M. ;

Ljungman, M. ;

Merajver, S. D. ;

Kleer, C. G. .

ONCOGENE, 2009, 28 (06) :843-853

[62] Mechanisms of cancer drug resistance [J].

Gottesman, MM .

ANNUAL REVIEW OF MEDICINE, 2002, 53 :615-627

[63] Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro [J].

Graham, SM ;

Jorgensen, HG ;

Allan, E ;

Pearson, C ;

Alcorn, MJ ;

Richmond, L ;

Holyoake, TL .

BLOOD, 2002, 99 (01) :319-325

[64] Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML) [J].

Guan, YH ;

Gerhard, B ;

Hogge, DE .

BLOOD, 2003, 101 (08) :3142-3149

[65] Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening [J].

Gupta, Piyush B. ;

Onder, Tamer T. ;

Jiang, Guozhi ;

Tao, Kai ;

Kuperwasser, Charlotte ;

Weinberg, Robert A. ;

Lander, Eric S. .

CELL, 2009, 138 (04) :645-659

[66] Preferential induction of apoptosis for primary human leukemic stem cells [J].

Guzman, ML ;

Swiderski, CF ;

Howard, DS ;

Grimes, BA ;

Rossi, RM ;

Szilvassy, SJ ;

Jordan, CT .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (25) :16220-16225

[67] PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo [J].

Hambardzumyan, Dolores ;

Becher, Oren J. ;

Rosenblum, Marc K. ;

Pandolfi, Pier Paolo ;

Manova-Todorova, Katia ;

Holland, Eric C. .

GENES & DEVELOPMENT, 2008, 22 (04) :436-448

[68] BCR-ABL activity and its response to drugs can be determined in CD34+ CML stem cells by CrkL phosphorylation status using flow cytometry [J].

Hamilton, A. ;

Elrick, L. ;

Myssina, S. ;

Copland, M. ;

Jorgensen, H. ;

Melo, J. V. ;

Holyoake, T. .

LEUKEMIA, 2006, 20 (06) :1035-1039

[69] N-cadherin expression level distinguishes reserved versus primed states of hematopoietic stem cells [J].

Haug, Jeffrey S. ;

He, Xi C. ;

Grindley, Justin C. ;

Wunderlich, Joshua P. ;

Gaudenz, Karin ;

Ross, Jason T. ;

Paulson, Ariel ;

Wagner, Kathryn P. ;

Xie, Yucai ;

Zhu, Ruihong ;

Yin, Tong ;

Perry, John M. ;

Hembree, Mark J. ;

Redenbaugh, Erin P. ;

Radice, Glenn L. ;

Seidel, Christopher ;

Li, Linheng .

CELL STEM CELL, 2008, 2 (04) :367-379

[70] PTEN-deficient intestinal stem cells initiate intestinal polyposis [J].

He, Xi C. ;

Yin, Tong ;

Grindley, Justin C. ;

Tian, Qiang ;

Sato, Toshiro ;

Tao, W. Andy ;

Dirisina, Raminarao ;

Porter-Westpfahl, Kimberly S. ;

Hembree, Mark ;

Johnson, Teri ;

Wiedemann, Leanne M. ;

Barrett, Terrence A. ;

Hood, Leroy ;

Wu, Hong ;

Li, Linheng .

NATURE GENETICS, 2007, 39 (02) :189-198

← 2 3 4 5 6 7 8 9 10 11 →